Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2016-03-11

Clinical Trial Update: 1068GCC Evaluate Efficacy & Explore Mechanism of Acupuncture in Treating Bortezomib-induced Peripheral Neuropathy (BIPN) in Multiple Myeloma [NA]

View source ↗

Summary

Clinical trial investigating acupuncture for bortezomib-induced peripheral neuropathy in multiple myeloma has completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Acupuncture
  • Bortezomib (bortezomib)

Snippet

Sponsor: University of Maryland, Baltimore | Conditions: Peripheral Neuropathies, Multiple Myeloma | NA | Status: COMPLETED | Results posted: 2016-03-11